Kuehn Hye Sun, Bosticardo Marita, Arrieta Antonio C, Stoddard Jennifer L, Pala Francesca, Niemela Julie E, Gil Silva Agustin A, King Paighton L, Esteve-Sole Ana, Naveen Amreen, Anaya Eduardo, Truong Pooi Meng, Delmonte Ottavia M, Buchbinder David K, Rosenzweig Sergio D, Notarangelo Luigi D
Immunology Service, Department of Laboratory Medicine, National Institutes of Health Clinical Center, Bethesda, Md.
Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
J Allergy Clin Immunol. 2025 Apr;155(4):1378-1385.e2. doi: 10.1016/j.jaci.2024.12.1082. Epub 2024 Dec 27.
Heterozygous immunoproteasome 20 S subunit beta 10 (PSMB10) mutations can cause severe combined immunodeficiency and Omenn syndrome. Hematopoietic stem cell transplantation in these patients is associated with severe complications and poor immune reconstitution, often resulting in death.
We sought to perform immunologic and molecular characterization of an infant with a PSMB10 heterozygous variant.
A heterozygous variant in PSMB10 (p.G201R) was identified in the index patient but not her parents. Detailed immunophenotyping and functional studies, including flow cytometry, immunoblotting, and T-cell development in artificial thymic organoids, were performed.
The patient presented with severe B-, natural killer-, and T-cell lymphopenia, with a progressive increase in memory CD4 T cells and loss of CD8 T cells, diminished Vbeta family diversity, and abnormal IL-7 signaling. Immunoproteasome protein expression (PSMB9 and PSMB10) was markedly reduced in the patient's cells, including PBMCs, EBV-transformed B cells, and fibroblasts, the mutation likely acting in a dominant-negative fashion. The patient's CD34 cells showed a normal early T-cell development but slightly impaired generation of CD3TCR αβ cells in artificial thymic organoids, and human thymus single-cell RNA sequencing demonstrated that PSMB10 is expressed in different subsets of cortical and medullary thymic epithelial cells. Collectively, these data indicate that PSMB10 mutations affect positive selection of CD8 T cells, generation of a diverse T-cell repertoire, and negative selection of autoreactive T cells.
The PSMB10 G201R variant is associated with reduced immunoproteasome expression levels that appear to play vital roles in hematopoietic and extrahematopoietic immune system development and function. PSMB10-associated thymoproteasome dysfunction leads to impaired thymopoiesis and the development of severe combined immunodeficiency and Omenn syndrome, suggesting possible benefit from thymus implantation.
杂合性免疫蛋白酶体20 S亚基β10(PSMB10)突变可导致严重联合免疫缺陷和奥门综合征。这些患者的造血干细胞移植与严重并发症及免疫重建不良相关,常导致死亡。
我们试图对一名携带PSMB10杂合变异的婴儿进行免疫学和分子特征分析。
在索引患者中鉴定出PSMB10的杂合变异(p.G201R),但其父母未携带该变异。进行了详细的免疫表型分析和功能研究,包括流式细胞术、免疫印迹以及人工胸腺类器官中的T细胞发育研究。
该患者出现严重的B细胞、自然杀伤细胞和T细胞淋巴细胞减少,记忆性CD4 T细胞逐渐增加而CD8 T细胞减少,Vβ家族多样性降低,以及白细胞介素-7信号异常。患者细胞(包括外周血单个核细胞、EB病毒转化的B细胞和成纤维细胞)中的免疫蛋白酶体蛋白表达(PSMB9和PSMB10)明显降低,该突变可能以显性负性方式起作用。患者的CD34细胞在人工胸腺类器官中显示早期T细胞发育正常,但CD3TCRαβ细胞的生成略有受损,人胸腺单细胞RNA测序表明PSMB10在皮质和髓质胸腺上皮细胞的不同亚群中表达。总体而言,这些数据表明PSMB10突变影响CD8 T细胞的阳性选择、多样化T细胞库的生成以及自身反应性T细胞的阴性选择。
PSMB10 G201R变异与免疫蛋白酶体表达水平降低有关,这似乎在造血和造血外免疫系统的发育及功能中起重要作用。PSMB10相关的胸腺蛋白酶体功能障碍导致胸腺生成受损以及严重联合免疫缺陷和奥门综合征的发生,提示胸腺植入可能有益。